Is Skinvive by Juvéderm FDA Approved? What You Need to Know

FDA Approval Status

Yes, Skinvive by Juvéderm is FDA approved. The product received clearance in 2023 specifically for improving skin quality and appearance in the cheeks and neck using a microdroplet injection method. This marks a significant expansion of the Juvéderm portfolio beyond traditional dermal fillers into the skin-quality space.

What It's Approved For

Skinvive is indicated for:

• Cheek skin quality improvement
• Neck skin quality enhancement
• Smoothing fine lines and improving skin texture in these areas

The microdroplet delivery system is central to the product's mechanism—ultra-fine injections of hyaluronic acid (HA) are placed in the superficial dermis to hydrate and plump the skin from within, rather than adding volume like traditional fillers.

The Microdroplet Difference

Unlike standard filler injections that create volume in deeper layers, Skinvive's microdroplet technique deposits smaller amounts of HA across a broader treatment area at a shallower depth. This approach targets skin quality, radiance, and fine lines rather than structural volume loss—positioning it as a complementary product to traditional fillers in your practice.

Practice Considerations

For medspa and aesthetic practice owners, Skinvive represents an opportunity to:

• Offer a skin-quality treatment distinct from volumizing fillers
• Treat patients seeking subtle, natural-looking skin improvement
• Expand revenue in the popular cheek and neck markets
• Educate clients on the difference between volume and hydration-based results

As with all FDA-approved injectables, verify current prescribing information, training requirements, and any updates to approved indications with Allergan (the manufacturer) and your state board, as regulatory guidance can evolve.

Bottom Line

Skinvive by Juvéderm is an FDA-approved option for practices looking to diversify their injectable menu with a skin-quality focused product. Proper training and patient consultation on realistic outcomes—and how it differs from traditional fillers—are essential for successful integration into your treatment offerings.